Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

NCT04782505 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DWJ1248

Sponsor

Daewoong Pharmaceutical Co. LTD.